AC BioScience Ltd is a clinical stage biotechnology company dedicated to developing innovative therapies for the treatment of tumoral and immunological pathologies.

Products, services, technology

S1P metabolites (ACB2003.4) as an angiogenic therapy for solid hypoxic cancers. Start with clinical trials Phase 2a in early 2023 for a combination treatment of metastatic pancreatic adenocarcinoma.
Beta-carboline derivative (ACB1801) to enhance the efficacy of checkpoint-inhibitor immune-therapy.


Route de la Corniche 4, 1066 Epalinges, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business